Works matching IS 02780232 AND DT 2013 AND VI 31 AND IP 4


Results: 12
    1

    Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.

    Published in:
    Hematological Oncology, 2013, v. 31, n. 4, p. 179, doi. 10.1002/hon.2036
    By:
    • Zinzani, Pier Luigi;
    • Pellegrini, Cinzia;
    • Merla, Emanuela;
    • Ballerini, Filippo;
    • Fabbri, Alberto;
    • Guarini, Attilio;
    • Pavone, Vincenzo;
    • Quintini, Gerlando;
    • Puccini, Benedetta;
    • Vigliotti, Maria Luigia;
    • Stefoni, Vittorio;
    • Derenzini, Enrico;
    • Broccoli, Alessandro;
    • Gandolfi, Letizia;
    • Quirini, Federica;
    • Casadei, Beatrice;
    • Argnani, Lisa;
    • Baccarani, Michele
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Sorafenib in patients with refractory or recurrent multiple myeloma.

    Published in:
    Hematological Oncology, 2013, v. 31, n. 4, p. 197, doi. 10.1002/hon.2043
    By:
    • Yordanova, Anna;
    • Hose, Dirk;
    • Neben, Kai;
    • Witzens‐Harig, Mathias;
    • Gütgemann, Ines;
    • Raab, Marc‐Steffen;
    • Moehler, Thomas;
    • Goldschmidt, Hartmut;
    • Schmidt‐Wolf, Ingo GH
    Publication type:
    Article
    11

    Issue Information.

    Published in:
    Hematological Oncology, 2013, v. 31, n. 4, p. i, doi. 10.1002/hon.2128
    Publication type:
    Article
    12